JP2005520606A - 発光容器を用いて体の外表面を治療する装置及び方法 - Google Patents
発光容器を用いて体の外表面を治療する装置及び方法 Download PDFInfo
- Publication number
- JP2005520606A JP2005520606A JP2003576047A JP2003576047A JP2005520606A JP 2005520606 A JP2005520606 A JP 2005520606A JP 2003576047 A JP2003576047 A JP 2003576047A JP 2003576047 A JP2003576047 A JP 2003576047A JP 2005520606 A JP2005520606 A JP 2005520606A
- Authority
- JP
- Japan
- Prior art keywords
- light
- container
- patch
- minutes
- luminous
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims description 72
- 238000011282 treatment Methods 0.000 claims description 82
- 239000000463 material Substances 0.000 claims description 49
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 38
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 13
- 206010000496 acne Diseases 0.000 claims description 13
- 239000003504 photosensitizing agent Substances 0.000 claims description 11
- 201000004624 Dermatitis Diseases 0.000 claims description 8
- 208000000260 Warts Diseases 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 210000004209 hair Anatomy 0.000 claims description 8
- 201000010153 skin papilloma Diseases 0.000 claims description 8
- 208000032544 Cicatrix Diseases 0.000 claims description 6
- 231100000241 scar Toxicity 0.000 claims description 6
- 230000037387 scars Effects 0.000 claims description 6
- 206010052428 Wound Diseases 0.000 claims description 5
- 208000027418 Wounds and injury Diseases 0.000 claims description 5
- 239000003860 topical agent Substances 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 4
- 235000019198 oils Nutrition 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 3
- 230000003712 anti-aging effect Effects 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 230000002165 photosensitisation Effects 0.000 claims description 3
- 235000019499 Citrus oil Nutrition 0.000 claims description 2
- 230000032683 aging Effects 0.000 claims description 2
- 239000010500 citrus oil Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000001678 irradiating effect Effects 0.000 claims 4
- 238000001429 visible spectrum Methods 0.000 claims 3
- 230000001954 sterilising effect Effects 0.000 claims 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 description 22
- 229960002749 aminolevulinic acid Drugs 0.000 description 21
- 206010028980 Neoplasm Diseases 0.000 description 19
- 201000011510 cancer Diseases 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 16
- 230000001225 therapeutic effect Effects 0.000 description 13
- 210000001519 tissue Anatomy 0.000 description 13
- 230000002087 whitening effect Effects 0.000 description 13
- 230000003902 lesion Effects 0.000 description 12
- 208000009621 actinic keratosis Diseases 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 230000000699 topical effect Effects 0.000 description 10
- 230000004044 response Effects 0.000 description 9
- -1 oxyline ester Chemical class 0.000 description 8
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 description 7
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 7
- 239000003054 catalyst Substances 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 229950003776 protoporphyrin Drugs 0.000 description 7
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 150000002978 peroxides Chemical class 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 201000004681 Psoriasis Diseases 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000004065 semiconductor Substances 0.000 description 5
- 206010041823 squamous cell carcinoma Diseases 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000003442 weekly effect Effects 0.000 description 5
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 239000012190 activator Substances 0.000 description 4
- 239000007844 bleaching agent Substances 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000004207 dermis Anatomy 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 238000002428 photodynamic therapy Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 208000004210 Pressure Ulcer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 235000013877 carbamide Nutrition 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 210000004919 hair shaft Anatomy 0.000 description 3
- 239000000416 hydrocolloid Substances 0.000 description 3
- 229910052744 lithium Inorganic materials 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 3
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 3
- 230000002940 repellent Effects 0.000 description 3
- 239000005871 repellent Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 229940034610 toothpaste Drugs 0.000 description 3
- 239000000606 toothpaste Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- ZHBOFZNNPZNWGB-UHFFFAOYSA-N 9,10-bis(phenylethynyl)anthracene Chemical compound C1=CC=CC=C1C#CC(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C#CC1=CC=CC=C1 ZHBOFZNNPZNWGB-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010004146 Basal cell carcinoma Diseases 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- 208000018035 Dental disease Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000013307 optical fiber Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N phenanthrene Chemical compound C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- 230000008832 photodamage Effects 0.000 description 2
- 238000001126 phototherapy Methods 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- YKSGNOMLAIJTLT-UHFFFAOYSA-N violanthrone Chemical compound C12=C3C4=CC=C2C2=CC=CC=C2C(=O)C1=CC=C3C1=CC=C2C(=O)C3=CC=CC=C3C3=CC=C4C1=C32 YKSGNOMLAIJTLT-UHFFFAOYSA-N 0.000 description 2
- MINDHVHHQZYEEK-UHFFFAOYSA-N (E)-(2S,3R,4R,5S)-5-[(2S,3S,4S,5S)-2,3-epoxy-5-hydroxy-4-methylhexyl]tetrahydro-3,4-dihydroxy-(beta)-methyl-2H-pyran-2-crotonic acid ester with 9-hydroxynonanoic acid Natural products CC(O)C(C)C1OC1CC1C(O)C(O)C(CC(C)=CC(=O)OCCCCCCCCC(O)=O)OC1 MINDHVHHQZYEEK-UHFFFAOYSA-N 0.000 description 1
- DXBHBZVCASKNBY-UHFFFAOYSA-N 1,2-Benz(a)anthracene Chemical compound C1=CC=C2C3=CC4=CC=CC=C4C=C3C=CC2=C1 DXBHBZVCASKNBY-UHFFFAOYSA-N 0.000 description 1
- DCCXNTCSVXAHAN-UHFFFAOYSA-N 1,5-dichloro-9,10-bis(2-phenylethynyl)anthracene Chemical compound C12=C(Cl)C=CC=C2C(C#CC=2C=CC=CC=2)=C2C(Cl)=CC=CC2=C1C#CC1=CC=CC=C1 DCCXNTCSVXAHAN-UHFFFAOYSA-N 0.000 description 1
- ISGNKKCVOWFMSF-UHFFFAOYSA-N 1-methoxy-9,10-bis(2-phenylethynyl)anthracene Chemical compound C12=CC=CC=C2C(C#CC=2C=CC=CC=2)=C2C(OC)=CC=CC2=C1C#CC1=CC=CC=C1 ISGNKKCVOWFMSF-UHFFFAOYSA-N 0.000 description 1
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- OUHYGBCAEPBUNA-UHFFFAOYSA-N 5,12-bis(phenylethynyl)naphthacene Chemical class C1=CC=CC=C1C#CC(C1=CC2=CC=CC=C2C=C11)=C(C=CC=C2)C2=C1C#CC1=CC=CC=C1 OUHYGBCAEPBUNA-UHFFFAOYSA-N 0.000 description 1
- FCNCGHJSNVOIKE-UHFFFAOYSA-N 9,10-diphenylanthracene Chemical class C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 FCNCGHJSNVOIKE-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 1
- 239000005751 Copper oxide Substances 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 102000003972 Fibroblast growth factor 7 Human genes 0.000 description 1
- 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 101001038006 Homo sapiens Lysophosphatidic acid receptor 3 Proteins 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 206010024774 Localised infection Diseases 0.000 description 1
- 102100040388 Lysophosphatidic acid receptor 3 Human genes 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 208000004550 Postoperative Pain Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 1
- 208000014151 Stomatognathic disease Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047642 Vitiligo Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 229940028420 bactroban Drugs 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 229960002227 clindamycin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- VNFPBHJOKIVQEB-UHFFFAOYSA-N clotrimazole Chemical compound ClC1=CC=CC=C1C(N1C=NC=C1)(C=1C=CC=CC=1)C1=CC=CC=C1 VNFPBHJOKIVQEB-UHFFFAOYSA-N 0.000 description 1
- 229960004022 clotrimazole Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910000431 copper oxide Inorganic materials 0.000 description 1
- COUNCWOLUGAQQG-UHFFFAOYSA-N copper;hydrogen peroxide Chemical compound [Cu].OO COUNCWOLUGAQQG-UHFFFAOYSA-N 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 125000003963 dichloro group Chemical group Cl* 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- ADRVRLIZHFZKFE-UHFFFAOYSA-N ethanediperoxoic acid Chemical compound OOC(=O)C(=O)OO ADRVRLIZHFZKFE-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000024963 hair loss Diseases 0.000 description 1
- 230000003463 hyperproliferative effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- XMFOQHDPRMAJNU-UHFFFAOYSA-N lead(ii,iv) oxide Chemical compound O1[Pb]O[Pb]11O[Pb]O1 XMFOQHDPRMAJNU-UHFFFAOYSA-N 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- PREAJQDJMZQQOQ-UHFFFAOYSA-M lithium;2-chlorobenzoate Chemical compound [Li+].[O-]C(=O)C1=CC=CC=C1Cl PREAJQDJMZQQOQ-UHFFFAOYSA-M 0.000 description 1
- PSBOOKLOXQFNPZ-UHFFFAOYSA-M lithium;2-hydroxybenzoate Chemical compound [Li+].OC1=CC=CC=C1C([O-])=O PSBOOKLOXQFNPZ-UHFFFAOYSA-M 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- KNJDBYZZKAZQNG-UHFFFAOYSA-N lucigenin Chemical compound [O-][N+]([O-])=O.[O-][N+]([O-])=O.C12=CC=CC=C2[N+](C)=C(C=CC=C2)C2=C1C1=C(C=CC=C2)C2=[N+](C)C2=CC=CC=C12 KNJDBYZZKAZQNG-UHFFFAOYSA-N 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 description 1
- 229960000988 nystatin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- MQKNLRFUHOJEGN-UHFFFAOYSA-N oxyline Natural products O1C(C)C(O)C(OC)CC1OC1C(OC)C(O)C(OC2C(CC(OC2C)OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)CC5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)OC)OC1C MQKNLRFUHOJEGN-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940112971 protopic Drugs 0.000 description 1
- 230000001698 pyrogenic effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229930187593 rose bengal Natural products 0.000 description 1
- 229940081623 rose bengal Drugs 0.000 description 1
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 description 1
- VDNLFJGJEQUWRB-UHFFFAOYSA-N rose bengal free acid Chemical compound OC(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C(O)=C(I)C=C21 VDNLFJGJEQUWRB-UHFFFAOYSA-N 0.000 description 1
- YYMBJDOZVAITBP-UHFFFAOYSA-N rubrene Chemical compound C1=CC=CC=C1C(C1=C(C=2C=CC=CC=2)C2=CC=CC=C2C(C=2C=CC=CC=2)=C11)=C(C=CC=C2)C2=C1C1=CC=CC=C1 YYMBJDOZVAITBP-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960004025 sodium salicylate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- IFLREYGFSNHWGE-UHFFFAOYSA-N tetracene Chemical compound C1=CC=CC2=CC3=CC4=CC=CC=C4C=C3C=C21 IFLREYGFSNHWGE-UHFFFAOYSA-N 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0616—Skin treatment other than tanning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N5/0603—Apparatus for use inside the body for treatment of body cavities
- A61N2005/0606—Mouth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
- A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
- A61N2005/0645—Applicators worn by the patient
- A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0651—Diodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/065—Light sources therefor
- A61N2005/0656—Chemical light sources
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/062—Photodynamic therapy, i.e. excitation of an agent
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Radiation-Therapy Devices (AREA)
- Surgical Instruments (AREA)
- Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36497602P | 2002-03-15 | 2002-03-15 | |
| PCT/US2003/008156 WO2003077996A2 (en) | 2002-03-15 | 2003-03-17 | A device and method for treatment of external surfaces of a body utilizing a light-emitting container |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005520606A true JP2005520606A (ja) | 2005-07-14 |
| JP2005520606A5 JP2005520606A5 (https=) | 2006-05-18 |
Family
ID=28041996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003576047A Withdrawn JP2005520606A (ja) | 2002-03-15 | 2003-03-17 | 発光容器を用いて体の外表面を治療する装置及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20050080465A1 (https=) |
| EP (1) | EP1490150A1 (https=) |
| JP (1) | JP2005520606A (https=) |
| AU (1) | AU2003222006A1 (https=) |
| CA (1) | CA2478567A1 (https=) |
| WO (1) | WO2003077996A2 (https=) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005025478A1 (ja) * | 2003-09-12 | 2006-11-16 | ヤーマン株式会社 | トリートメント装置 |
| JP2008253337A (ja) * | 2007-03-31 | 2008-10-23 | Yamaguchi Univ | 医療用発光装置 |
| JP2011255157A (ja) * | 2010-06-09 | 2011-12-22 | Forward Electronics Co Ltd | 光線治療パッチ |
| JP2014525317A (ja) * | 2011-08-26 | 2014-09-29 | マイケル ピー オニール | タトゥ除去システム及び方法 |
| JP2016514000A (ja) * | 2013-03-14 | 2016-05-19 | クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | 生体光材料およびその使用 |
| JP2017036277A (ja) * | 2015-08-13 | 2017-02-16 | ヤー チュン ション チー ユー シエン コン スー | 美容用シート |
| JP2017509433A (ja) * | 2014-04-01 | 2017-04-06 | クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | 組織充填剤組成物および使用方法 |
| US10881736B2 (en) | 2013-07-03 | 2021-01-05 | Klox Technologies Inc. | Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
| JP2022540769A (ja) * | 2019-06-25 | 2022-09-20 | デューサ ファーマシューティカルズ インコーポレイテッド | 光線性角化症の光線力学的治療の間の痛みを低減する方法 |
Families Citing this family (91)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9119705B2 (en) | 1998-06-08 | 2015-09-01 | Thermotek, Inc. | Method and system for thermal and compression therapy relative to the prevention of deep vein thrombosis |
| US7813787B2 (en) * | 2002-07-31 | 2010-10-12 | Inspektor Research Systems Bv | Dental implement and method for tooth surface inspection |
| US7713294B2 (en) | 2002-08-28 | 2010-05-11 | Nomir Medical Technologies, Inc. | Near infrared microbial elimination laser systems (NIMEL) |
| WO2004103298A2 (en) * | 2003-05-16 | 2004-12-02 | Waverx, Inc. | Apparatus and method for the treatment of infectious disease in keratinized tissue |
| US8574278B2 (en) | 2006-05-09 | 2013-11-05 | Thermotek, Inc. | Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation |
| WO2005007060A2 (en) | 2003-07-18 | 2005-01-27 | Thermotek, Inc. | Compression sequenced thermal therapy system |
| US8128672B2 (en) | 2006-05-09 | 2012-03-06 | Thermotek, Inc. | Wound care method and system with one or both of vacuum-light therapy and thermally augmented oxygenation |
| US20050053895A1 (en) | 2003-09-09 | 2005-03-10 | The Procter & Gamble Company Attention: Chief Patent Counsel | Illuminated electric toothbrushes emitting high luminous intensity toothbrush |
| GB0324254D0 (en) * | 2003-10-16 | 2003-11-19 | Euphotonics Ltd | Apparatus for illuminating a zone of mammalian skin |
| US20080038685A1 (en) * | 2003-12-15 | 2008-02-14 | Showa Yakuhin Kako Co., Ltd. | Light Irradiation Device For Oral Cavity |
| WO2005077458A1 (ja) * | 2004-02-13 | 2005-08-25 | Fancl Corporation | 化学発光利用化粧・美容方法、皮膚照射美容用発光体及び化粧・美容用具 |
| JP2007536987A (ja) * | 2004-05-13 | 2007-12-20 | ウェイブレクス，インコーポレイテッド | 角化組織の伝染性疾病治療用装置及び方法 |
| US20050256552A1 (en) * | 2004-05-17 | 2005-11-17 | White Robert L | Toenail fungus eradicator |
| US10016583B2 (en) | 2013-03-11 | 2018-07-10 | Thermotek, Inc. | Wound care and infusion method and system utilizing a thermally-treated therapeutic agent |
| US10765785B2 (en) | 2004-07-19 | 2020-09-08 | Thermotek, Inc. | Wound care and infusion method and system utilizing a therapeutic agent |
| WO2006020602A1 (en) * | 2004-08-09 | 2006-02-23 | Lumiport, Llc | Skin treatment phototherapy device |
| BRPI0519218A2 (pt) * | 2004-12-22 | 2009-01-06 | Gillette Co | reduÇço do crescimento de cabelos ou pÊlos |
| US8109981B2 (en) * | 2005-01-25 | 2012-02-07 | Valam Corporation | Optical therapies and devices |
| US20060173514A1 (en) * | 2005-02-02 | 2006-08-03 | Advanced Photodynamic Technologies, Inc. | Wound treatment device for photodynamic therapy and method of using same |
| US7153131B2 (en) * | 2005-02-07 | 2006-12-26 | Crohn Enterprises Ltd. | Intraoral illumination device |
| US7582067B2 (en) * | 2005-03-15 | 2009-09-01 | Ted Gerard Van Acker | Prepared medication applicator including a swab and a pharmacological active agent |
| US20070036770A1 (en) * | 2005-08-12 | 2007-02-15 | Wagner Darrell O | Biologic device for regulation of gene expression and method therefor |
| TW200722070A (en) * | 2005-12-13 | 2007-06-16 | Health & Welfare Technology Inc | One kind of apparatus for stimulating acupuncture points on the face |
| US8048089B2 (en) | 2005-12-30 | 2011-11-01 | Edge Systems Corporation | Apparatus and methods for treating the skin |
| WO2007106856A2 (en) * | 2006-03-14 | 2007-09-20 | Allux Medical, Inc. | Phototherapy device and method of providing phototherapy to a body surface |
| US9566088B2 (en) | 2006-03-29 | 2017-02-14 | Edge Systems Llc | Devices, systems and methods for treating the skin |
| WO2014151104A1 (en) | 2013-03-15 | 2014-09-25 | Edge Systems Llc | Devices, systems and methods for treating the skin |
| EP2051774B1 (en) * | 2006-08-07 | 2012-09-12 | Koninklijke Philips Electronics N.V. | System of plaster and radiation device |
| US20080076836A1 (en) * | 2006-09-01 | 2008-03-27 | Cardiac Pacemakers, Inc | Method and apparatus for using light to enhance cell growth and survival |
| US20090012515A1 (en) * | 2007-07-06 | 2009-01-08 | Hoenig Peter A | Devices, systems and methods for treating tissues |
| KR101836310B1 (ko) | 2008-01-04 | 2018-03-08 | 엣지 시스템즈 엘엘씨 | 피부 처리 장치 및 방법 |
| US7896908B2 (en) * | 2008-01-08 | 2011-03-01 | Oregon Aesthetic Technologies | Skin therapy system |
| WO2009097451A1 (en) | 2008-01-29 | 2009-08-06 | Edge Systems Corporation | Apparatus and method for treating the skin |
| US8192418B2 (en) * | 2009-03-10 | 2012-06-05 | Medtronic, Inc. | Releasing a material within a medical device via an optical feedthrough |
| US9724784B2 (en) * | 2009-03-10 | 2017-08-08 | Medtronic, Inc. | Optical feedthrough for medical devices |
| US20100234927A1 (en) * | 2009-03-11 | 2010-09-16 | Mei-Chun Lin | Lighting apparatus of facial and lighting method thereof |
| US8399731B2 (en) * | 2009-03-19 | 2013-03-19 | Covidien Lp | Phototherapy wound treatment |
| WO2011014484A1 (en) * | 2009-07-27 | 2011-02-03 | Earl Cranor | Combined thermal and chemiluminescent reaction system |
| WO2012040854A1 (en) * | 2010-09-29 | 2012-04-05 | Yumalite Inc. | Head mounted light therapy device |
| CN103339222A (zh) * | 2010-10-24 | 2013-10-02 | 克禄美科技股份有限公司 | 组合的热和化学发光反应系统 |
| US20120271219A1 (en) * | 2011-04-19 | 2012-10-25 | David John Weisgerber | Combined Energy and Topical Composition Application For Regulating the Condition of Mammalian Skin |
| US10512587B2 (en) | 2011-07-27 | 2019-12-24 | Thermotek, Inc. | Method and apparatus for scalp thermal treatment |
| EP2550925A1 (en) * | 2011-07-28 | 2013-01-30 | Eduardo Antonio Gomez de Diego | Multipurpose portable laser depilationdevice |
| US10022554B2 (en) | 2013-03-15 | 2018-07-17 | Johnson & Johnson Consumer Inc. | Light therapy bandage system |
| US10272257B2 (en) | 2011-09-08 | 2019-04-30 | Johnson & Johnson Consumer, Inc. | Light therapy platform inductive mask and charger |
| US10195458B2 (en) | 2011-09-08 | 2019-02-05 | Johnson & Johnson Consumer Inc. | Light therapy platform enhanced controller |
| US9789333B2 (en) | 2011-09-08 | 2017-10-17 | Johnson & Johnson Consumer Inc. | Light therapy platform system |
| US10090694B2 (en) | 2011-09-08 | 2018-10-02 | Johnson & Johnson Consumer Inc. | Light therapy platform mobile phone charger |
| US10092770B2 (en) | 2011-09-08 | 2018-10-09 | Johnson & Johnson Consumer Inc. | Light therapy spot applicator |
| US10434325B2 (en) | 2011-09-08 | 2019-10-08 | Johnson & Johnson Consumer Inc. | Light therapy platform mobile device applications |
| US8771328B2 (en) | 2011-09-08 | 2014-07-08 | La Lumiere Llc | Light therapy platform system |
| US10213618B2 (en) | 2011-09-08 | 2019-02-26 | Johnson & Johnson Consumer, Inc. | Light therapy platform combination mask |
| US20130103123A1 (en) | 2011-10-14 | 2013-04-25 | Sazzadur Rahman Khan | Light-Emitting Devices for Wound Healing |
| TWI670098B (zh) * | 2011-10-14 | 2019-09-01 | 日商日東電工股份有限公司 | 用於創傷癒合之發光裝置、光療系統及發光裝置與光療系統之用途 |
| US9687669B2 (en) | 2011-11-09 | 2017-06-27 | John Stephan | Wearable light therapy apparatus |
| WO2013132397A1 (en) | 2012-03-06 | 2013-09-12 | Koninklijke Philips N.V. | Patient interface having illuminated portion |
| US20130281913A1 (en) | 2012-04-20 | 2013-10-24 | Klox Technologies Inc. | Biophotonic compositions and methods for providing biophotonic treatment |
| US11116841B2 (en) | 2012-04-20 | 2021-09-14 | Klox Technologies Inc. | Biophotonic compositions, kits and methods |
| EP2841121B1 (en) | 2012-04-24 | 2020-12-02 | Thermotek, Inc. | System for therapeutic use of ultra-violet light |
| US9168178B2 (en) * | 2012-05-22 | 2015-10-27 | Covidien Lp | Energy-delivery system and method for controlling blood loss from wounds |
| US20140088670A1 (en) * | 2012-09-25 | 2014-03-27 | Ines Verner Rashkovsky | Devices and methods for stimulation of hair growth |
| US10300180B1 (en) | 2013-03-11 | 2019-05-28 | Thermotek, Inc. | Wound care and infusion method and system utilizing a therapeutic agent |
| CA2906787C (en) | 2013-03-15 | 2020-02-18 | Carewear Corp. | Light and ultrasonic transducer device |
| US10166402B2 (en) | 2013-05-16 | 2019-01-01 | Excelitas Technologies Corp. | Visible light photo-disinfection patch |
| US9669233B2 (en) | 2013-11-11 | 2017-06-06 | Thermotek, Inc. | Method and system for wound care |
| DE202013105127U1 (de) * | 2013-11-13 | 2015-02-18 | Swiss Red Ag | Raum und Lichtdeckensystem zur Durchführung der Photodynamischen Therapie |
| US11358002B2 (en) | 2014-05-29 | 2022-06-14 | Raymond R. Blanche | Method and apparatus for non-thermal nail, foot, and hand fungus treatment |
| US9555262B2 (en) | 2014-05-29 | 2017-01-31 | New Skin Therapies, LLC | Method and apparatus for non-thermal nail, foot, and hand fungus treatment |
| CN107073282B (zh) * | 2014-10-28 | 2020-09-29 | 首尔伟傲世有限公司 | 具有紫外元件的粘合装置 |
| EP3237055B1 (en) | 2014-12-23 | 2020-08-12 | Edge Systems LLC | Devices and methods for treating the skin using a rollerball or a wicking member |
| US10179229B2 (en) | 2014-12-23 | 2019-01-15 | Edge Systems Llc | Devices and methods for treating the skin using a porous member |
| US10646319B2 (en) * | 2015-12-30 | 2020-05-12 | Colgate-Palmolive Company | Thin, flexible powered oral care device |
| US10765885B2 (en) * | 2016-02-26 | 2020-09-08 | Nanoco Technologies Ltd. | Phototherapy mask with quantum dot phosphors |
| AU2017250458A1 (en) | 2016-04-13 | 2018-11-08 | Inspektor Research Systems B.V. | Bi-frequency dental examination |
| ES2967941T3 (es) * | 2016-04-26 | 2024-05-06 | Peace Out Inc | Apósito hidrocoloide medicinal para el tratamiento del acné |
| CA3025009C (en) | 2016-05-26 | 2022-07-26 | San Diego State University Research Foundation | Photoeradication of microorganisms with pulsed purple or blue light |
| CA3031991A1 (en) * | 2016-07-27 | 2018-02-01 | Z2020 Llc | Componentry and devices for light therapy delivery and methods related thereto |
| US20190083809A1 (en) | 2016-07-27 | 2019-03-21 | Z2020, Llc | Componentry and devices for light therapy delivery and methods related thereto |
| US10912739B2 (en) | 2017-10-16 | 2021-02-09 | Peace Out Inc. | Hydrocolloid-based skin treatment |
| US11020605B2 (en) | 2018-05-29 | 2021-06-01 | Carewear Corp. | Method and system for irradiating tissue with pulsed blue and red light to reduce muscle fatigue, enhance wound healing and tissue repair, and reduce pain |
| KR102783037B1 (ko) * | 2019-05-16 | 2025-03-19 | 주식회사 엘지생활건강 | 얼굴 미용기기 및 마스크 시트 |
| US11291474B2 (en) | 2020-01-06 | 2022-04-05 | Ed F. Nicolas | Skin treatment tool applicator tip |
| USD1065551S1 (en) | 2021-09-10 | 2025-03-04 | Hydrafacial Llc | Skin treatment device |
| USD1016615S1 (en) | 2021-09-10 | 2024-03-05 | Hydrafacial Llc | Container for a skin treatment device |
| CA3231401A1 (en) | 2021-09-10 | 2023-03-16 | Hydrafacial Llc | Devices, systems and methods for treating the skin |
| USD1116120S1 (en) | 2021-10-11 | 2026-03-03 | Hydrafacial Llc | Skin treatment device |
| USD1042807S1 (en) | 2021-10-11 | 2024-09-17 | Hydrafacial Llc | Skin treatment tip |
| US11684586B1 (en) | 2022-02-28 | 2023-06-27 | Peace Out, Llc | Anhydrous hydrocolloid matrix comprising homogeneously distributed encapsulated therapeutic agents |
| USD1112778S1 (en) | 2022-03-04 | 2026-02-10 | Hydrafacial Llc | Light therapy device for skin care |
| USD1084369S1 (en) | 2023-02-10 | 2025-07-15 | Hydrafacial Llc | Skin treatment tip |
| USD1052743S1 (en) | 2024-04-27 | 2024-11-26 | Goddess's Messenger Ltd | Led light therapy mask |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999052597A1 (en) * | 1998-04-10 | 1999-10-21 | The Board Of Trustees Of The University Of Arkansas | Photomatrix device |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL152290B (nl) | 1965-09-08 | 1977-02-15 | American Cyanamid Co | Werkwijze ter bereiding van chemiluminescerende mengsels. |
| DE2029899A1 (de) | 1970-06-18 | 1971-12-30 | Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt | Verfahren zum Vernetzen von Füllstoffen enthaltendem natürlichem und synthetischem Kautschuk bzw. diese enthaltenden Mischungen |
| US3691085A (en) | 1970-07-13 | 1972-09-12 | American Cyanamid Co | Method of controlling the lifetime of oxalate ester chemiluminescent reactions |
| US3704231A (en) | 1971-02-16 | 1972-11-28 | American Cyanamid Co | Chemiluminescent additives |
| US6267914B1 (en) | 1999-11-02 | 2001-07-31 | Omniglow Corporation | Variable chemiluminescent process and product |
-
2003
- 2003-03-17 CA CA002478567A patent/CA2478567A1/en not_active Abandoned
- 2003-03-17 EP EP03717989A patent/EP1490150A1/en not_active Withdrawn
- 2003-03-17 JP JP2003576047A patent/JP2005520606A/ja not_active Withdrawn
- 2003-03-17 WO PCT/US2003/008156 patent/WO2003077996A2/en not_active Ceased
- 2003-03-17 AU AU2003222006A patent/AU2003222006A1/en not_active Abandoned
-
2004
- 2004-09-14 US US10/941,043 patent/US20050080465A1/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999052597A1 (en) * | 1998-04-10 | 1999-10-21 | The Board Of Trustees Of The University Of Arkansas | Photomatrix device |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2005025478A1 (ja) * | 2003-09-12 | 2006-11-16 | ヤーマン株式会社 | トリートメント装置 |
| JP2008253337A (ja) * | 2007-03-31 | 2008-10-23 | Yamaguchi Univ | 医療用発光装置 |
| JP2011255157A (ja) * | 2010-06-09 | 2011-12-22 | Forward Electronics Co Ltd | 光線治療パッチ |
| JP2014525317A (ja) * | 2011-08-26 | 2014-09-29 | マイケル ピー オニール | タトゥ除去システム及び方法 |
| US9381167B2 (en) | 2011-08-26 | 2016-07-05 | Michael P. O'Neil | Optical treatment methods |
| JP2018069093A (ja) * | 2011-08-26 | 2018-05-10 | オーエヌ ライト サイエンシーズ インコーポレイテッド | タトゥ除去システム及び方法 |
| JP2016514000A (ja) * | 2013-03-14 | 2016-05-19 | クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | 生体光材料およびその使用 |
| US12496344B2 (en) | 2013-03-14 | 2025-12-16 | Fle International S.R.L. | Biophotonic materials and uses thereof |
| US11324823B2 (en) | 2013-03-14 | 2022-05-10 | Klox Technologies Inc. | Biophotonic materials and uses thereof |
| US10881736B2 (en) | 2013-07-03 | 2021-01-05 | Klox Technologies Inc. | Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds |
| US10772990B2 (en) | 2014-04-01 | 2020-09-15 | Klox Technologies Inc. | Tissue filler compositions and methods of use |
| JP2017509433A (ja) * | 2014-04-01 | 2017-04-06 | クロックス テクノロジーズ インコーポレイテッドＫｌｏｘ Ｔｅｃｈｎｏｌｏｇｉｅｓ Ｉｎｃ． | 組織充填剤組成物および使用方法 |
| JP2017036277A (ja) * | 2015-08-13 | 2017-02-16 | ヤー チュン ション チー ユー シエン コン スー | 美容用シート |
| JP2022540769A (ja) * | 2019-06-25 | 2022-09-20 | デューサ ファーマシューティカルズ インコーポレイテッド | 光線性角化症の光線力学的治療の間の痛みを低減する方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1490150A1 (en) | 2004-12-29 |
| WO2003077996A2 (en) | 2003-09-25 |
| US20050080465A1 (en) | 2005-04-14 |
| AU2003222006A1 (en) | 2003-09-29 |
| CA2478567A1 (en) | 2003-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005520606A (ja) | 発光容器を用いて体の外表面を治療する装置及び方法 | |
| US7084389B2 (en) | Hand held led device | |
| Bown | Photodynamic therapy for photochemists | |
| Moseley et al. | Ambulatory photodynamic therapy: a new concept in delivering photodynamic therapy | |
| CN105228696B (zh) | 用于波长特定的光疗法的医用装置 | |
| Tsai et al. | Photodynamic therapy of oral dysplasia with topical 5‐aminolevulinic acid and light‐emitting diode array | |
| Oh et al. | Therapeutic application of light emitting diode: Photo-oncomic approach | |
| Hürlimann et al. | Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion | |
| CN102343126A (zh) | 用于处理成纤维细胞和衍生成纤维细胞的哺乳动物细胞和胶原的低强度光疗法 | |
| JP2005521432A (ja) | 生細胞の光調節のための方法および装置 | |
| EP1819360A1 (en) | Method of treating microorganisms in the oral cavity via photodynamic therapy employing a non-coherent light source | |
| US20060093561A1 (en) | Method of treating microorganisms in the oral cavity | |
| JP5074691B2 (ja) | 化学発光利用化粧・美容方法、皮膚照射美容用発光体及び化粧・美容用具 | |
| ES2293334T3 (es) | Aparato para iluminar una zona de piel de mamifero. | |
| Kübler et al. | Photodynamic therapy of head and neck cancer | |
| CN108337881A (zh) | 治疗皮肤病症的小型uvb光疗装置 | |
| Wyss et al. | Photomedicine of the endometrium: experimental concepts | |
| Ch | Photo dynamic therapy in oral diseases | |
| Gossner et al. | Photodynamic therapy of gastric cancer | |
| Velpula et al. | Photodynamic therapy: A new modality treatment in pre-cancer and cancer patients | |
| Hode et al. | Laser phototherapy | |
| Khurana et al. | Photodynamic therapy-A ray towards periodontics | |
| RU2398607C1 (ru) | Способ терапии фоновых предраковых, злокачественных и метастатических заболеваний | |
| Gu et al. | Light-emitting diodes for healthcare and well-being | |
| Yu | Photodynamic therapy: the light treatment for cutaneous non-melanoma malignancies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060317 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060317 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20081106 |
|
| A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A073 Effective date: 20091218 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100422 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20101006 |